More than 1 million Americans live with tremors, slowed movement and speech changes caused by Parkinson's disease—a ...

Researchers in the University of Georgia's College of Veterinary Medicine have engineered a live bacterium to function as the delivery driver for Levodopa, the gold-standard drug for treatment of the ...

Gain Therapeutics’s (NASDAQ:GANX) is one of the 12 hot penny stocks to invest in right now. At the Society for Neuroscience ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

A new anti-inflammatory drug could speed up treatment effectiveness for a neurological disease that 50 Australians are ...

Scott Rider of South Carolina is one of over 1 million people in the United States with Parkinson's disease. Working closely ...

A new study shows how failing mitochondria and rising oxidative stress may set off key steps in Parkinson’s disease.

Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...

Type II diabetes and Parkinson's disease may not appear to have much in common but a look below the surface reveals important molecular similarities that provide a potential target for fighting ...

This story was commissioned by the River City Journalism Fund Mary Eagan, 71, stares at the body-height punching bag, her delicate hands buried in a pair of giant red boxing gloves. On this warm ...

Local institutions led studies on AI coaching for diabetes, psychedelic treatments for postpartum depression, and music ...

A mini-peptide has been created that delays the early damage caused by Parkinson's disease and promises a way to slow down the disease.